Literature DB >> 7729483

Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion.

P Eldin de Pécoulas1, L K Basco, B Abdallah, M K Djé, J Le Bras, A Mazabraud.   

Abstract

We describe here a rapid procedure to predict the resistance of Plasmodium falciparum to pyrimethamine or cycloguanil. The method consists of amplification by PCR of the DHFR gene followed by restriction enzyme digestion of codons 16 and 108. Three different enzymes are used to cut the wild-type, 108-threonine mutant, and 108-asparagine mutant gene. Since every natural antifolate-resistant isolate identified until now carries a mutation in codon 108, determination of the nature of this codon can predict the sensitivity of any P. falciparum isolate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729483     DOI: 10.1006/expr.1995.1060

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum.

Authors:  R Durand; J Eslahpazire; S Jafari; J F Delabre; A Marmorat-Khuong; J P di Piazza; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Demonstration of a high level of parasite population homology by quantification of Plasmodium falciparum alleles in matched peripheral, placental, and umbilical cord blood samples.

Authors:  Sayeh Jafari-Guemouri; Nicaise Tuikue Ndam; Gwladys Bertin; Emily Renart; Sokhna Sow; Jean-Yves Le Hesran; Philippe Deloron
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.

Authors:  L K Basco; R Tahar; P Ringwald
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

4.  Molecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyrimethamine combination.

Authors:  Virginie Menemedengue; Khalifa Sahnouni; Leonardo Basco; Rachida Tahar
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

5.  Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.

Authors:  Anwar Ahmed; Deepak Bararia; Sumiti Vinayak; Mohammed Yameen; Sukla Biswas; Vas Dev; Ashwani Kumar; Musharraf A Ansari; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

6.  Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

Authors:  A Nzila-Mounda; E K Mberu; C H Sibley; C V Plowe; P A Winstanley; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 7.  Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.

Authors:  Christian Nsanzabana; Djibrine Djalle; Philippe J Guérin; Didier Ménard; Iveth J González
Journal:  Malar J       Date:  2018-02-08       Impact factor: 2.979

8.  Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.

Authors:  Erasto V Mbugi; Benezeth M Mutayoba; Allen L Malisa; Sakurani T Balthazary; Thomas B Nyambo; Hassan Mshinda
Journal:  Malar J       Date:  2006-10-31       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.